Laboratory for Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, van der Boechorststraat 7, 1081 BT, Amsterdam, the Netherlands.
Pflugers Arch. 2011 Jul;462(1):155-63. doi: 10.1007/s00424-011-0960-3. Epub 2011 Apr 13.
In recent years, it has become evident that heart failure is not solely due to reduced contractile performance of the heart muscle as impaired relaxation is evident in almost all heart failure patients. In more than half of all heart failure patients, diastolic dysfunction is the major cardiac deficit. These heart failure patients have normal (or preserved) left ventricular ejection fraction, but impaired diastolic function evident from increased left ventricular end-diastolic pressure. Perturbations at the cellular level which cause impaired relaxation of the heart muscle involve changes in Ca(2+)-handling proteins, extracellular matrix components, and myofilament properties. The present review discusses the deficits in myofilament function observed in human heart failure and the most likely underlying causal protein changes. Moreover, the consequences of impaired myofilament function for in vivo diastolic dysfunction are discussed taking into account the reported changes in Ca(2+) handling.
近年来,人们已经清楚地认识到心力衰竭不仅仅是由于心肌收缩性能下降所致,因为几乎所有心力衰竭患者都存在舒张功能障碍。在超过一半的心力衰竭患者中,舒张功能障碍是主要的心脏缺陷。这些心力衰竭患者的左心室射血分数正常(或保留),但舒张功能受损,左心室舒张末期压力增加。导致心肌舒张功能障碍的细胞水平的扰动涉及钙处理蛋白、细胞外基质成分和肌丝特性的变化。本综述讨论了在人类心力衰竭中观察到的肌丝功能缺陷,以及最有可能的潜在因果蛋白变化。此外,考虑到报道的钙处理变化,讨论了肌丝功能障碍对体内舒张功能障碍的影响。